Anti‐spike antibody durability after <scp>SARS‐CoV</scp>‐2 vaccination in adolescent solid organ transplant recipients
John McAteer(Johns Hopkins University), Douglas Mogul(Johns Hopkins Medicine), Scott R. Auerbach(Children's Hospital Colorado), Teresa Po‐Yu Chiang(Johns Hopkins University), Emily R. Perito(University of California, San Francisco), Saeed Mohammad(Lurie Children's Hospital), Dorry L. Segev(New York University), William A. Werbel(Johns Hopkins University), Noelle H. Ebel(Stanford University), Rivka Abedon(Johns Hopkins University), Caroline X. Qin(Johns Hopkins University), Olga Charnaya(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Lara Danziger‐Isakov(Cincinnati Children's Hospital Medical Center), Divya Kalluri(Johns Hopkins University), Amy G. Feldman(Children's Hospital Colorado), Ashley M. Thomas(Johns Hopkins University), Evelyn Hsu(Seattle Children's Hospital)
Cited by 3
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
|JAMA|2021|536
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
|New England Journal of Medicine|2015|450